Hans C. Rumke

Rotterdam, ZH, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 38 publications

Uncertainties with starting new vaccinations: a comparison between polio and covid-19 vaccination

Uncertainties with starting new vaccinations: a comparison between polio and covid-19 vaccination

Journal: Nederlands tijdschrift voor geneeskunde

Published: August 29, 2022

BCG: an almost 100-year-old vaccine

BCG: an almost 100-year-old vaccine

Journal: Nederlands tijdschrift voor geneeskunde

Published: October 08, 2020

Vaccination against Haemophilus influenzaetype b; why and how?

Vaccination against Haemophilus influenzaetype b; why and how?

Journal: Nederlands tijdschrift voor geneeskunde

Published: September 17, 2020

Measles vaccination: why and how?

Measles vaccination: why and how?

Journal: Nederlands tijdschrift voor geneeskunde

Published: May 13, 2020

Diphtheria: a 'forgotten' disease?

Diphtheria: a 'forgotten' disease?

Journal: Nederlands tijdschrift voor geneeskunde

Published: October 15, 2019

Hypersensitivity reactions and vaccines

Hypersensitivity reactions and vaccines

Journal: Nederlands tijdschrift voor geneeskunde

Published: December 09, 2017

A tailor-made approach for causality assessment for ADR reports on drugs and vaccines.

A tailor-made approach for causality assessment for ADR reports on drugs and vaccines.

Journal: Pharmacoepidemiology and drug safety

Published: November 13, 2017

Impact and cost-effectiveness of different vaccination strategies to reduce the burden of pneumococcal disease among elderly in the Netherlands.

Impact and cost-effectiveness of different vaccination strategies to reduce the burden of pneumococcal disease among elderly in the Netherlands.

Journal: PloS one

Published: October 17, 2017

Elevated Immune Response Among Children 4 Years of Age With Pronounced Local Adverse Events After the Fifth Diphtheria, Tetanus, Acellular Pertussis Vaccination.

Elevated Immune Response Among Children 4 Years of Age With Pronounced Local Adverse Events After the Fifth Diphtheria, Tetanus, Acellular Pertussis Vaccination.

Journal: The Pediatric infectious disease journal

Published: April 22, 2017

Immunogenicity and safety of cell-derived MF59®-adjuvanted A/H1N1 influenza vaccine for children.

Immunogenicity and safety of cell-derived MF59®-adjuvanted A/H1N1 influenza vaccine for children.

Journal: Human vaccines & immunotherapeutics

Published: January 27, 2015

Adverse events and association with age, sex and immunological parameters of Q fever vaccination in patients at risk for chronic Q fever in the Netherlands 2011.

Adverse events and association with age, sex and immunological parameters of Q fever vaccination in patients at risk for chronic Q fever in the Netherlands 2011.

Journal: Vaccine

Published: July 23, 2014

Immunogenicity and tolerability of an MF59-adjuvanted, egg-derived, A/H1N1 pandemic influenza vaccine in children 6-35 months of age.

Immunogenicity and tolerability of an MF59-adjuvanted, egg-derived, A/H1N1 pandemic influenza vaccine in children 6-35 months of age.

Journal: The Pediatric infectious disease journal

Published: July 01, 2014

Showing 1-12 of 38

Last Updated: 09/26/2026